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Abstract
The orexigenic peptide, ghrelin is known to influence function of GnRH neurons, however, the direct effects of the
hormone upon these neurons have not been explored, yet. The present study was undertaken to reveal expression
of growth hormone secretagogue receptor (GHS-R) in GnRH neurons and elucidate the mechanisms of ghrelin
actions upon them. Ca2+-imaging revealed a ghrelin-triggered increase of the Ca2+-content in GT1-7 neurons kept in a
steroid-free medium, which was abolished by GHS-R-antagonist JMV2959 (10µM) suggesting direct action of ghrelin.
Estradiol (1nM) eliminated the ghrelin-evoked rise of Ca2+-content, indicating the estradiol dependency of the
process. Expression of GHS-R mRNA was then confirmed in GnRH-GFP neurons of transgenic mice by single cell
RT-PCR. Firing rate and burst frequency of GnRH-GFP neurons were lower in metestrous than proestrous mice.
Ghrelin (40nM-4μM) administration resulted in a decreased firing rate and burst frequency of GnRH neurons in
metestrous, but not in proestrous mice. Ghrelin also decreased the firing rate of GnRH neurons in males. The
ghrelin-evoked alterations of the firing parameters were prevented by JMV2959, supporting the receptor-specific
actions of ghrelin on GnRH neurons. In metestrous mice, ghrelin decreased the frequency of GABAergic mPSCs in
GnRH neurons. Effects of ghrelin were abolished by the cannabinoid receptor type-1 (CB1) antagonist AM251 (1µM)
and the intracellularly applied DAG-lipase inhibitor THL (10µM), indicating the involvement of retrograde
endocannabinoid signaling. These findings demonstrate that ghrelin exerts direct regulatory effects on GnRH
neurons via GHS-R, and modulates the firing of GnRH neurons in an ovarian-cycle and endocannabinoid dependent
manner.
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Introduction
The orexigenic peptide, ghrelin was initially discovered in rat
stomach [1], where it is secreted into the circulation under
certain physiological conditions such as fasting [2-4]. Synthesis
of ghrelin was later confirmed in other organ systems, too [5]. It
serves as endogenous ligand for the growth hormone
secretagogue receptor (GHS-R) [1], which belongs to the G-
protein coupled receptor (GPCR) family [6]. Expression of the
receptor was detected in the hypothalamo-pituitary unit and
several other brain loci [6-9].
The wide-spread expression of ghrelin in various organs
shows that it is involved in diverse functions such as growth
hormone secretion [10], regulation of food intake and energy
balance [2], control of ACTH secretion [11], regulation of insulin
and blood glucose levels [12,13], processes of learning and
memory, modulation of synaptic plasticity [8,14], and control of
reproductive functions [5,15]. Ghrelin production was also
revealed in the homeostatic centers of the hypothalamus and
the pituitary [1,2,16-18].
Earlier studies have indicated that hypothalamic neurons
involved in the central control of the gonadal axis were
powerfully affected by ghrelin. Decreased gonadotropin-
releasing hormone-1 (GnRH) release was demonstrated from
hypothalamic explants after ex vivo ghrelin administration in
male rats [19]. Furthermore, diminished GnRH secretion by
hypothalamic fragments of ovariectomized (OVX) female rats
was found following ghrelin application [20]. Kisspeptin mRNA
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expression was also suppressed by ghrelin in the medial
preoptic area (mPOA) [21]. Since GnRH neurons play a pivotal
role in the orchestration of the pituitary-gonadal axis, any
ghrelin-induced modulation of the GnRH neuronal system has
impact on various events of reproductive physiology. In
accordance with rodent studies, human data also showed
involvement of ghrelin in the inhibition of spontaneous
secretion of luteinizing hormone (LH) [22-24]. While the role of
ghrelin upon central, hypothalamic regulatory mechanisms of
reproduction has been well-established, the way how ghrelin
exerts its central effects on the neuronal networks governing
reproduction centrally, and particularly on GnRH neurons, has
not been fully elucidated, yet.
In the present study, we addressed the putative, direct
effects of ghrelin upon GnRH neurons. The performed
electrophysiological and molecular biological studies tested the
hypothesis that ghrelin acted on GnRH neurons via GHS-R and
decreased the firing activity of these cells. Since most of GnRH
neurons express ERβ [25,26] and numerous functions of GnRH
neurons strongly depend on the estrous-cycle and level of
circulating estradiol [27,28], we investigated the effect of
ghrelin in GnRH neurons of metestrous and proestrous mice.
Change in the firing activity of GnRH neurons correlates with
the excitatory GABAergic neurotransmission via GABAA-
receptors (GABAA-R) [29-31], therefore action of ghrelin on the
GABAergic input to the GnRH neurons was also studied. In
addition, literature data revealed that effect of ghrelin in
hypothalamic neurons involved release of endocannabinoid by
postsynaptic neurons [32-34], thus the experiments presented
here also examined whether modulatory action of ghrelin was
manifested via endocannabinoid retrograde signaling to
GABAergic neuronal afferents of GnRH neurons utilizing
GABAA-Rs in neurotransmission.
Materials and Methods
Ethics statement
All studies were carried out with permissions from the Animal
Welfare Committee of the Institute of Experimental Medicine
Hungarian Academy of Sciences (Permission Number:
A5769-01) and in accordance with legal requirements of the
European Community (Decree86/609/EEC). All animal
experimentation described was conducted in accord with
accepted standards of humane animal care and all efforts were
made to minimize suffering. Sacrifice of animals was carried
out by decapitation in deep anesthesia by isoflurane inhalation.
Cell culture
GnRH-producing immortalized GT1-7 neurons [35] were
cultured in Dulbecco Modified Eagle Medium (DMEM, Sigma,
St. Louis, MO, US) containing high-glucose and supplemented
with 10% fetal calf serum (FCS, Sigma) and 5% horse serum
(HS, Sigma). Prior to 17β-estradiol (E2; 1nM, Sigma)
treatment, the culturing medium was replaced with a steroid/
thyroid- and phenol red-free one and cells were cultured in this
medium for 24hrs. Subsequently, one group of the cells was
treated with E2 for 24h whereas the other group was cultured
further in the steroid-free medium for another 24h. The cells
were then processed for calcium imaging experiments.
Animals
Adult, gonadally intact female and male mice were used from
local colonies bred at the Medical Gene Technology Unit of the
Institute of Experimental Medicine (IEM). They were housed in
light (12:12 light-dark cycle, lights on at 06:00h) - and
temperature (22±2°C) controlled environment, with free access
to standard food and tap water. GnRH-green-fluorescent
protein (GnRH-GFP) transgenic mice (n=70) bred on a
C57BL/6J genetic background were used for
electrophysiological experiments. In this animal model, a GnRH
promoter segment drives selective GFP expression in the
majority of GnRH neurons [36]. Phase of the estrous cycle was
checked by both evaluating vaginal smear [37] and visual
observation of the vaginal opening using the method
elaborated recently in the Jackson Laboratory [38].
Calcium imaging
Cultured GT1-7 neurons were loaded with the calcium-
sensitive fluorescent dye Fura-2AM (1µM; Molecular Probes,
Eugene, Oregon, US) in loading buffer Hanks’ Balanced Salt
Solution (HBSS) containing 0.1% DMSO and Pluronic-F127
(1µM, Molecular Probes) for 1.5h at room temperature. After
washing with HBSS, the experiments were carried out in HBSS
at room temperature. In each experiment, ghrelin (acylated-
ghrelin; 1µM; Tocris, Bristol, UK) was pipetted directly into the
bath solution after a 1min baseline recording and then ghrelin
remained in the HBSS during recording. The GHS-R antagonist
JMV2959 (10µM; Aeterna Zentaris GmBH, Frankfurt,
Germany) was added to the HBSS 10min before ghrelin
application.
In the case of E2 pre-treatment, the cells were pre-treated
with E2 (1nM) as described in the “Cell culture” section and all
of rinsing and recording HBSS solutions contained the same
concentration of E2, which means that E2 was continuously
present in the HBSS during recording.
The experiments were carried out with ARGUS HiSCA Ca2+-
imaging system (Hamamatsu Photonics, Hamamatsu, Japan).
The ratio of the fluorescent signals obtained at excitation
wavelengths of 340 and 380nm was used to determine
changes in the intracellular Ca2+-concentration of the soma of
the cells. Ca2+-imaging recordings were baseline corrected,
then the area-under-curve data of the records representing the
net change in the intracellular free Ca2+-content were analyzed.
Baseline correction was carried out by subtracting the
background fluorescence measured from a region in the
coverslip free of neurons [39].
Brain slice preparation and recordings
Mice were deeply anesthetized using Isoflurane inhalation.
The brain was removed rapidly and immersed in ice cold
sodium-free artificial cerebrospinal fluid (Na-free aCSF)
bubbled with a mixture of 95% O2 and 5% CO2. The solution
contained the following (in mM): saccharose 252, KCl 3.5,
NaHCO3 26, MgSO4 1.2, NaH2PO4 1.25, CaCl2 2.5, glucose 10.
Hypothalamic blocks were dissected and 350µm-thick coronal
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slices (between 1.42-0.6mm measured from the bregma
according to Paxinos’ Mouse Brain Atlas [40]) were prepared
from the medial septum/preoptic area with a VT-1000S
vibratome (Leica) in the ice-cold oxygenated Na-free aCSF.
The slices were equilibrated in normal aCSF (in mM): NaCl
135, KCl 3.5, NaHCO3 26, MgSO4 1.2, NaH2PO4 1.25, CaCl2
2.5, glucose 10, saturated with O2/CO2 for 1h. Initial
temperature of aCSF was 33°C which was left to cool to room
temperature during equilibration.
Male mice and group of metestrous mice were sacrificed
between 1100-1200h, whereas proestrous mice and another
group of metestrous mice were sacrificed between
1400-1500h.
Recordings were carried out in oxygenated aCSF at 33°C.
Axopatch-200B patch-clamp amplifier, Digidata-1322A data
acquisition system, and pCLAMP 9.2 software (Molecular
Devices Co., Silicon Valley, California, US) were used for
recording. Cells were visualized with a BX51WI IR-DIC
microscope (Olympus Co., Tokyo, Japan). The patch
electrodes (OD=1.5mm, thin wall, Hilgenberg GmBH, Malsfeld,
Germany) were pulled with a Flaming-Brown P-97 puller
(Sutter Instrument Co., Novato, CA, US) and polished with an
MF-830 microforge (Narishige Inc., Tokyo, Japan).
GnRH-GFP neurons were identified by brief illumination at
470nm using an epifluorescent filter set, based on their green
fluorescence, typical fusiform shape and topographic location
in the preoptic area [36].
Loose-patch or whole-cell patch-clamp measurements were
carried out with an initial control recording (4min), then ghrelin
(4nM-4μM) was added to the aCSF and the recording
continued for a subsequent 11min. When the GHS-R
antagonist JMV2959 (10µM), the CB1 antagonist AM251 (1µM;
Tocris), the ionotropic glutamate receptor blocker kynurenic
acid (2mM) or the GABAA-R antagonist picrotoxin (100µM)
were used, they were added to the aCSF 10min before starting
the recording. Intracellular Ca2+-pool was depleted by applying
thapsigargin (1µM) in the aCSF for 30min before patch
clamping. Each neuron served as its own control when drug
effects were evaluated.
Loose-patch-clamp experiments
Loose-patch measurements were carried out as described
earlier [41]. Briefly, pipette potential 0mV, pipette resistance
1-2MΩ, resistance of loose-patch seal 7-40MΩ. The pipette
solution contained (in mM): NaCl 150, KCl 3.5, CaCl2 2.5,
MgCl2 1.3, HEPES 10, glucose 10 (pH=7.3 with NaOH).
Whole-cell patch-clamp experiments
The GnRH neurons were measured as described earlier [41].
Briefly, the neurons were voltage-clamped at holding potential
-70mV, the intracellular pipette solution contained (in mM):
HEPES 10, KCl 140, EGTA 5, CaCl2 0.1, Mg-ATP 4, Na-GTP
0.4 (pH=7.3 with NaOH). The resistance of the patch
electrodes was 2-3MΩ. Spike-mediated transmitter release was
blocked in all experiments by adding the voltage-sensitive Na-
channel inhibitor tetrodotoxin (TTX, 750nM, Tocris) to the
aCSF 10min before miniature postsynaptic currents (mPSCs)
were recorded. The mPSCs recorded under the circumstances
used in our experiments were related to GABAA-R activation
[41,42].
Current clamp experiments were carried out at 0pA holding
current. The aCSF contained ionotropic glutamate receptor
blocker kynurenic acid (2mM, Sigma) and GABAA-R blocker
picrotoxin (100µM, Sigma) to block fast glutamatergic and
GABAergic neurotransmission. In order to examine role of L-
type voltage gated calcium channels, nifedipine (inhibitor of the
L-type channels) was also added to the aCSF (10µM, Sigma).
The inihibitors were added to the aCSF 10min before starting
recording.
The source of endogenous cannabinoids that regulate
GABAergic afferents to GnRH neurons upon ghrelin
administration was investigated by adding the diacylglycerol
(DAG) lipase inhibitor tetrahydrolipstatin (THL, also known as
orlistat; 10µM; Tocris) to the intracellular solution to block 2-
arachidonoylglycerol (2-AG) synthesis. To minimize THL spill
and therefore any extracellular effect of THL, GnRH cells were
approached rapidly (<1min) and the flow rate of aCSF was
increased from 5-6 to 8-9 ml/min. Just before release of the
positive pressure in the pipette touching the GnRH neuron, the
flow rate was restored to 5-6 ml/min to avoid any mechanical
movement of the slice. During this short period (<1min)
extracellular effect of THL can be considered as negligible,
since volume of the recording chamber is small (1.5ml)
comparing to the volume of aCSF washing THL out of the
chamber. The pipette solution containing THL was allowed to
equilibrate with the intracellular milieu of the cell for 20 min
before starting recording.
Harvesting, cDNA synthesis, pre-amplification and real-
time PCR of GnRH-GFP neurons
In order to harvest cytoplasm from GnRH-GFP neurons for
single-cell PCR experiment, patch pipettes were pulled from
capillaries heated previously at 300C for 6h and filled with
autoclaved intracellular pipette solution not containing Mg-ATP
and Na-GTP. After establishing the whole-cell patch
configuration, cytoplasm was harvested by applying gentle
negative pressure under visual control [43,44]. Cytoplasmic
samples of 10 cells obtained from four male transgenic mice
were used.
The harvested cytoplasmic pool was processed for in vitro
reverse transcription using SuperScript VILO cDNA Synthesis
Kit (Life Technologies, Carlsbad, CA, US). We introduced pre-
amplification with 14 cycles for selected targets according to
manufacturer’s protocol using TaqMan PreAmp Master Mix
(Life Technologies). Low cycle number ensured unbiased
amplification and quantitative measurement of gene
expression. Subsequently, we performed quantitative real-time
PCR on a ViiA7 Real-Time PCR System (Life Technologies)
with TaqMan Gene Expression Assays (Life Technologies).
Inventoried assays used in both pre-amplification and realtime
PCR were as follows: Gapdh (assay ID: Mm99999915_g1);
Kiss1r (Mm00475046_m1); Gnrh (Mm01315605_m1); Ghsr
(Mm00616415_m1). To avoid detection of genomic DNA, each
assay was designed to span exons.
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Statistical analysis
Each experimental group included 6-7 animals in the
measurements. Recordings were stored and analyzed off-line.
Event detection was performed using the Clampfit module of
the PClamp9.2 software (Molecular Devices). Bursts were
defined according to Lee et al [45]. Mean firing rate was
calculated as number of spikes divided by the length of the
respective period (4min or 11min). Burst frequency was
calculated by dividing number of bursts with the length of the
respective time period. Intraburst frequency was calculated by
dividing number of spikes with the length of the respective
burst. Percentage changes resulted from ghrelin application
were calculated by dividing the value to be analyzed before
(4min) and after (the subsequent 11 min) ghrelin
administration. Instantaneous frequency (i.e. event frequency
at the rate of the current and the previous event) was
calculated using the Clampfit module of the PClamp software.
Group data were expressed as mean±standard error (SEM).
Statistical significance was analyzed using the Student’s t-test
or ANOVA followed by Newman-Keuls post-hoc test
(GraphPad Software Inc., La Jolla, California, US), and
considered at p<0.05 (i.e. 95% confidence interval).
Results
Ghrelin increased the intracellular free Ca2+-content in
GT1-7 neurons
In order to test effect of ghrelin in GT1-7 neurons, the
hormone was applied into the bath of the cells cultured in
steroid-free medium, and the change in the intracellular free
Ca2+-content was measured. Ca2+-imaging demonstrated that
ghrelin (1µM) evoked a robust increase in the intracellular Ca2+-
content which started in less than 1min (36 cells in three
repeated experiments; Figure 1a). Pretreatment of the cells
with the GHS-R antagonist JMV2959 (10µM, 10min) eliminated
the ghrelin-evoked elevation of the intracellular free Ca2+-
concentration suggesting involvement of the GHS-R (36 cells in
three repeated experiments; Figure 1b). The ghrelin-triggered
rise in the intracellular Ca2+-content was also abolished by
applying 17β-estradiol (E2, 1nM, 24h) in the steroid-free
medium indicating an interaction between the ghrelin and E2
signaling mechanisms in GT1-7 neurons (36 cells in three
repeated experiments; Figure 1c). The area-under-curve data
representing the net change in the intracellular free Ca2+-
concentration showed a significantly higher value when ghrelin
was added alone than the one obtained after JMV2959 or E2
pretreatment (Figure 1d; p<0.0001).
GnRH neurons expressed Ghsr mRNA
We employed GnRH-GFP transgenic mice, in which the
green fluorescent neurons were clearly distinguishable in the
medial septum and the mPOA. Individual GFP-expressing
GnRH neuronal cells were identified in the brain slices and
then their cytoplasmic content was harvested by patch pipettes.
To validate GnRH neurons, the expression of two characteristic
markers, GnRH and kisspeptin1 receptor mRNAs (Gnrh and
Kiss1r) was monitored. Expression of both Gnrh and Kiss1r
mRNAs was verified in GnRH-GFP samples at cycle threshold
(Ct) values of 20.4 and 27, respectively. Amplification curve
shows that GnRH neurons also expressed GHS-R mRNA
(Ghsr) at Ct 29.6 (pool of 10 cells from 3 animals, Figure 2).
Two controls were applied, a non-template control and a non-
GFP cell control (pool of 10 GFP-negative neurons chosen
from the close vicinity of the GFP-positive neurons from 3
animals). The measurements demonstrated no expression of
Ghsr mRNA in these controls (not shown).
Firing characteristics of GnRH neurons of the female
and male mice
Loose-patch recordings of the GnRH-GFP neurons of the
mouse brain slices showed burst firing both in female and male
mice (Figure 3a-c). Nevertheless, both mean firing rate and
burst frequency were significantly lower in metestrous (mean
firing rate=0.21±0.04Hz; burst frequency=0.027±0.008Hz,
Figure 3a) than in proestrous mice (mean firing
rate=0.64±0.15Hz; burst frequency=0.119±0.031Hz; Figure 3b)
(p<0.05 for both mean firing rate and burst frequency). Both
mean firing rate and burst frequency were higher in male mice
(mean firing rate=0.40±0.06Hz; burst frequency=0.08±0.026Hz;
Figure 3c) than in metestrous, but lower than in proestrous
mice.
Bar graph presents the mean firing rate values of GnRH
neurons in the female and male mice (Figure 3d) and
demonstrates that mean firing rate was significantly higher in
both proestrous female (16 cells from 5 animals) and male (14
cells from 5 animals) than in the metestrous female (18 cells
from 6 animals) mice (p<0.05). The basic burst parameters
such as burst frequency, events-in-burst, and intraburst
frequency are indicated in Table 1. The burst frequency value
was significantly higher in the proestrous female and male than
in metestrous female mice (p<0.05), whereas events-in-burst
and intraburst frequency showed no difference.
Ghrelin decreased firing of GnRH neurons in
metestrous and male but not in proestrous mice
Ghrelin (4nM) administration in GnRH neurons of the
metestrous mice revealed no change in any of the firing
parameters measured (mean firing rate from 0.2±0.03 to
0.19±0.02Hz, instantaneous frequency from 6.0±0.4 to
5.8±0.7Hz in 4 neurons from 2 animals, not shown). Higher
concentration of ghrelin (40nM) diminished mean firing rate
from 0.21±0.02 to 0.17±0.02Hz (80.9±7.4%), and
instantaneous frequency from 5.9±0.6 to 4.7±0.5Hz, duration
(period from the point when ghrelin started to act till its effect
vanished) was 8.5±2.6min in 4 of 5 neurons (from 2 animals)
(Figure 4a, p<0.05). 400nM ghrelin decreased mean firing rate
significantly from 0.22±0.03 to 0.12±0.03Hz (54.54±9.34%) and
instantaneous frequency from 6.4±0.6 to 4.5±0.4Hz (p<0.05)
and duration was 21.2±4.1min in 13 of 15 neurons (from 4
animals, not shown). 4µM ghrelin reduced mean firing rate from
0.21±0.03 to 0.12±0.02Hz (57.1±6.2%), instantaneous
frequency from 6.09±0.33 to 4.2±0.44Hz, and burst frequency
from 0.027±0.008 to 0.016±0.006Hz (61.8±14.87%)
significantly with duration of 22.6±3.4min in 12 of 14 neurons
(from 5 animals) (Figure 4b; p<0.05). Second ghrelin
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administration (the same concentration as the first one) applied
to the same neuron 5min after wash-out exerted no effect.
Table 1 shows that ghrelin application exerted no significant
change in the events-in-burst (2.5±0.606 events) and intraburst
frequency (6.54±2.22Hz) parameters. Amplitude and shape of
the action currents showed no change upon ghrelin treatment
at any concentration applied (insets at 4µM in Figure 4b).
When the effect of ghrelin (4µM) on the firing of GnRH neurons
of the proestrous mice was investigated, no significant
alteration could be detected in any of the firing parameters (in
11 neurons from 4 animals), mean firing rate changed from
0.64±0.15 to 0.67±0.12Hz (104.8±9.41%) (Figure 4c),
instantaneous frequency from 10.2±0.8 to 10.6±0.7Hz, burst
frequency from 0.119±0.031 to 0.111±0.028Hz (93.7±8.04%),
events-in-burst from 3.788±0.737 to 4.649±0.821 events
(123.6±25.8%), and intraburst frequency from 6.42±2.97 to
6.87±2.85Hz (107.7±5.8%) (Table 1), suggesting that the ability
of ghrelin to influence firing activity of GnRH neurons was
estrous cycle-dependent. Ghrelin (4µM) administration resulted
in significantly reduced firing activity in male mice in 12 of 15
Figure 1.  Effect of ghrelin on the intracellular free Ca2+-content of the GT1-7 neurons.  a) Ghrelin (1 µM) administration in an
estrogen-free medium resulted in an increase in the intracellular Ca2+-content. b) The GHS-R antagonist JMV2959 (10 µM, 10 min)
abolished the action of ghrelin. c) Estradiol (E2, 1 nM, 24 h) treatment eliminated the effect of ghrelin on the intracellular Ca2+-
concentration. d) Bar graph of the area-under-curve data representing the net change in the free Ca2+-content. *=p<0.0001. Arrow
shows the onset of ghrelin administration.
doi: 10.1371/journal.pone.0078178.g001
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neurons (from 4 animals), mean firing rate changed from
0.40±0.04 to 0.24±0.03Hz (60.5±5.82%), instantaneous
frequency from 8.0±0.6 to 6.2±0.5Hz, and burst frequency from
0.08±0.026 to 0.054±0.028Hz (68.5±9.43%) (Figure 4d;
p<0.05) with duration of 20.4±3.7min, whereas amplitude,
events-in-burst and intraburst frequency parameters were not
influenced (Table 1). Bar graph shows the percentage changes
in the mean firing rate resulted from ghrelin application (Figure
4e), demonstrating that ghrelin significantly decreased mean
firing rate in the metestrous female and male (p<0.05), but not
in the proestrous female mice. Dose-response curve of ghrelin
effect on mean firing rate in metestrous mice showed that
EC50 was 52.2nM (Figure 4f). When metestrous mice were
sacrificed in the afternoon, ghrelin (4µM) decreased mean firing
rate to 57.6±6.2% (from 0.21±0.02 to 0.12±0.03Hz) to an
extent similar to the value found in the experiments performed
in the morning (not shown). Instantaneous frequency of firing
also diminished (from 5.97±0.47 to 4.8±0.31Hz) in 4 of 5
neurons (from 3 animals), and duration was 21.7±2.8min. The
results, therefore, revealed no circadian time dependency of
the effect of ghrelin.
Simultaneous blockade of Glu-Rs and GABAA-Rs eliminated
the effect of ghrelin (mean firing rate from 0.22±0.02 to
0.23±0.02Hz, instantaneous frequency from 6.05±0.37 to
6.12±0.33Hz), showing involvement of fast neurotransmission
in its action in 4 neurons (from 2 animals) (Figure 5a).
Pretreatment of GnRH neurons of brain slice of metestrous
mice with JMV2959 (10µM, 10min) inhibited the effect of
ghrelin (4µM) (in 11 neurons). The mean firing rate did not
change significantly (from 0.2±0.03 to 0.2±0.03Hz
(107.5±6.41%) and instantaneous frequency from 6.11±0.34 to
6.0±0.29Hz) (Figure 5b), demonstrating involvement of GHS-R.
JMV2959 alone had no effect on the firing parameters. The
observed effect of ghrelin (4µM) was also abolished by
treatment of the slice with the endocannabinoid receptor type-1
(CB1) antagonist AM251 (1µM, 10min, 10 neurons, 3 animals).
Figure 2.  Expression of GHS-R mRNA in GnRH-GFP neurons.  Expression of GHS-R mRNA in GnRH-GFP neurons was
demonstrated by single cell real-time PCR. The amplification plot shows the expression of Gnrh (Ct: 20.4), Kiss1r (Ct: 27) and
Gapdh (Ct: 22.4) genes. The regular amplification curve of Ghsr with Ct values of 29.6 proves the expression of GHS-R mRNA.
doi: 10.1371/journal.pone.0078178.g002
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The mean firing rate did not alter significantly (from 0.25±0.02
to 0.24±0.03Hz) (Figure 5c) and the instantaneous frequency
(from 7.05±0.46 to 7.0±0.39Hz) suggesting that
endocannabinoid signaling mechanism was implied in the
process. In order to determine source of Ca2+ in the effect of
ghrelin, thapsigargin (1µM, 30min) was applied to deplete
intracellular Ca2+ pools. Thapsigargin was unable to influence
effect of 4µM ghrelin (mean firing rate changed to 61.9±5.7%
from 0.21±0.03 to 0.13±0.03Hz, instantaneous frequency from
6.1±0.30 to 4.2±0.41Hz, duration was 22.4±3.6min, p<0.05 in 4
of 4 neurons, 2 animals) (Figure 5d). Bar graph shows that no
significant changes in the mean firing rate could be observed
when ghrelin was co-applied with JMV2959, the AM251,
kynurenic acid and picrotoxin, whereas thapsigargin was
ineffective (Figure 5e). Current clamp measurement revealed
that ghrelin (4 µM) triggered slight depolarization (by
Figure 3.  Recordings of firing of GnRH neurons in the brain slice of the female (a,b) and male (c) mice.  d) Firing rate of
GnRH neurons is higher in proestrous than in metestrous female and male mice. Met=metestrus; Pro=proestrus; *=p<0.05.
doi: 10.1371/journal.pone.0078178.g003
Table 1. Basic burst parameters (before ghrelin application) and the percentage they changed to (after ghrelin
administration).
 Basic burst parameters Changes resulted from ghrelin
 bf (Hz) eb (events) ibf (Hz) bf % eb % ibf %
Metestrus 0.027±0.008 2.50±0.606 6.54±2.219 61.8±14.87* 134.3±28.84 119±28.8
Proestrus 0.119±0.031* 3.78±0.737 6.42±2.972 93.7±8.04 123.6±25.82 107.7±5.8
Male 0.080±0.026* 2.80±0.329 6.06±0.855 68.5±9.43* 139.6±44.75 122±15.7
bf=burst frequency; eb=events-in-burst; ibf=intraburst frequency. *=p<0.05
doi: 10.1371/journal.pone.0078178.t001
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Figure 4.  Effect of ghrelin on the firing of the GnRH neurons from the brain slice of the female (metestrus and proestrus)
and male mice.  a and b) Ghrelin (40 nM N=4 and 4 µM N=14) decreased the firing rate in the metestrus with no change in the
shape of the individual spikes (insets). Time course of the instantaneous frequency is figured under the firing recordings. c) In
proestrus, firing rate showed no change (N=11). d) Ghrelin administration in the male mouse resulted in a decrease in the firing rate
(N=15). e) Bar graph shows the significant changes in the firing rate in the metestrous female (40nM-4 µM but not at 4 nM) and
male, whereas ghrelin exerted no effect in the proestrous female mice. f) Dose-response curve of effect of ghrelin on the firing in
metestrous mice (0%=full effect, 100%=no effect). Met=metestrus; Pro=proestrus. Arrow shows onset of ghrelin administration
whereas double arrow marks wash-out. *=p<0.05.
doi: 10.1371/journal.pone.0078178.g004
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3.2±0.6mV from -65.4±0.9mV) in GnRH neurons in the
presence of TTX, kynurenic acid and picrotoxin suggesting
direct effect of ghrelin in these neurons (Figure 5f). This effect
was eliminated by nifedipine administration (Figure 5g)
showing role of L-type voltage gated calcium channels in this
action.
Effect of ghrelin on the GABAergic mPSCs of GnRH
neurons in metestrous mice
In order to demonstrate the direct action of ghrelin on GnRH
neurons of brain slice from metestrous mice, GABAergic
miniature postsynaptic currents (mPSCs) were recorded using
whole cell patch clamp method, and with 750nM tetrodotoxin
(TTX) in the aCSF to block voltage-gated sodium channels and
thus, propagation of the action potentials. Administration of
ghrelin (4µM) resulted in a significant decrease in the mean
frequency of the mPSCs in GnRH neurons (Figures 6a, 12 of
14 neurons from 4 animals, p<0.05), it changed to 58.4±6.72%
of the values before ghrelin application (from 1.11±0.256 to
0.64±0.151Hz). Mean instantaneous frequency also diminished
(from 34.6±5.32 to 20.4±4.48Hz). Amplitude of the mPSCs,
however, showed no alteration (from 32.7±2.40 to
30.90±2.91pA). Rise and decay time constants of the individual
mPSCs revealed no modification, either (τr from 6.42±1.54 to
7.05±1.72ms; whereas τd from 28.7±1.96 to 27.2±1.99ms) as
can be seen in the insets of Figure 6a. Time course of the
instantaneous frequency of the mPSCs also showed the
ghrelin-induced alteration (Figure 6a). These results
demonstrated a presynaptic modulation of the GABA-drive by
ghrelin. Pretreatment of the slices with AM251 (1µM, 10min)
eliminated the action of ghrelin on the mean frequency of
mPSCs in 11 neurons (from 1.58±0.20 to 1.70±0.33Hz,
108±12.24%, 4 animals) and instantaneous frequency (from
44.3±6.2 to 47.8±5.8Hz) (Figure 6b), suggesting involvement of
the endocannabinoid system. Implication of a retrograde
endocannabinoid signaling mechanism was confirmed by
intracellular application of the DAG-lipase inhibitor THL (10µM)
which also abolished the effect of ghrelin on the mean
frequency of mPSCs in the 10 neurons (3 animals) measured
(from 1.48±0.28 to 1.80±0.37Hz) and instantaneous frequency
(from 40.3±7.44 to 48.5±8.1Hz) (Figure 6c), revealing a direct
effect of the hormone in the GnRH neurons. Bar graph
summarizes the effect of ghrelin on the mean frequency of the
mPSCs and inhibition of the ghrelin-triggered action by
antagonizing CB1 and blocking 2-AG synthesis (Figure 6d).
Discussion
Previous studies described indirect ghrelin effects on GnRH
neurons via modulation of kisspeptin neurons [46,47]. The
present study provides evidence for direct action of ghrelin on
GnRH secreting neurons. Accordingly, 1) GHS-R mediated the
effect of ghrelin in GnRH neurons; 2) ghrelin affected GnRH
neurons in an estrous-cycle dependent manner; 3) action of
ghrelin involved activation of a retrograde endocannabinoid
signaling mechanism targeting GABAergic neurotransmission.
GHS-R mediated the effect of ghrelin in GnRH neurons
The first evidence for the direct action of ghrelin came from
our calcium imaging measurements in GT1-7 neurons, where a
robust increase in the intracellular free Ca2+-level was recorded
upon ghrelin administration. Similar rise in the Ca2+-content
after ghrelin administration has recently been observed in
GT1-7 neurons [48]. In addition, our results showed inhibition
of the ghrelin-evoked elevation of the Ca2+-concentration by the
GHS-R antagonist JMV2959 confirming the presence of
functional and active GHS-Rs in GT1-7 neurons. The proof for
mRNA expression of Ghsr in GnRH neurons of GnRH-GFP
transgenic mice further supported the presence of GHS-R in
the GnRH-producing neurons. The expression of ghrelin
receptor suggested that binding of ghrelin to its receptor could
evoke direct, specific effect in GnRH-producing neurons.
Ghrelin affects GnRH neurons in an estrous-cycle
dependent manner
The study has also revealed that pretreatment of GT1-7
neurons with E2 abolished the ghrelin-triggered increase in the
Ca2+-content, suggesting an interaction between the ghrelin-
activated and the E2-modulated signal transduction pathways.
This finding has been supported by results demonstrating that
male and OVX female rats were significantly more sensitive
than intact female rats to the orexigenic effects of both centrally
and systemically administered ghrelin [49]. Similar interaction
was concluded by other researchers presenting reduced
anorexigenic effects of a GHS-R antagonist treatment in mice
after estrogen supplementation [50]. These findings indicate a
convergence of the two signaling systems and an increased
regulatory potential of ghrelin at low E2 milieu. Nevertheless,
the intriguing question is the common point(s) of the two
pathways. Our present result that E2 inhibited the ghrelin-
evoked rise in the Ca2+-content in GT1-7 neurons suggested
convergence elements of the pathways upstream to the Ca2+-
sources. The pathways coupled to GHS-R and the membrane-
associated estrogen receptor (ER) could explain the
interaction, as proposed in Figure 7. Both of GHS-R and
membrane-associated ER are coupled to G-proteins, and the
ghrelin/E2-activated pathways involve phosphatidylinositol 4,5-
bisphosphate (PIP2), phospholipase-C (PLC), and the voltage-
gated Ca2+-channels (Figure 7) [6,51-57]. Nevertheless, this
concept requires further elaboration.
The loose patch clamp electrophysiology measurements
demonstrated burst-type firing in most of the GnRH neurons
recorded, a pattern characteristic for GnRH neurons in both
males and females [45,58-60]. However, firing rate and burst
frequency in GnRH neurons were significantly higher in
proestrous than metestrous mice. Estrous-cycle dependency of
the firing rate of the GnRH neurons has already been
suggested in a mouse model, where firing parameters in OVX
and E2 supplemented mice were compared [59,61-63]. In this
model, higher firing rate was observed during positive E2
feedback than under negative feedback, correlating with the
proestrus-afternoon and metestrus phases of the estrous-cycle,
respectively. Extracellular recordings in the mediobasal
hypothalamus also showed volleys of firing preceding LH
pulses in ewes and rats [64-66]. Interestingly, in a GnRH-
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Figure 5.  Effect of antagonists on the ghrelin-modulated firing activity and resting potential of GnRH neurons in
metestrous mice.  a) Block of fast neurotransmission by kynurenic acid (kyn) and picrotoxin (pic) eliminated the action of ghrelin
(N=4). b) The GHS-R antagonist JMV2959 also abolished effect of ghrelin (N=11). c) Antagonizing the endocannabinoid CB1
receptor by AM251 abolished effect of ghrelin (N=10). d) Depletion of the intracellular Ca2+-pools by thapsigargin (thap) showed no
effect on the ghrelin-induced decrease in the firing activity (N=4). e) Bar graph shows elimination of effect of ghrelin by inhibition of
fast neurotransmission, by antagonizing ghrelin receptor or by block of CB1 but not by depleting the intracellular Ca2+-sources. f)
Current clamp measurement showed slight depolarization upon ghrelin administration. g) Depolarizing effect of ghrelin was
eliminated by nifedipine. *=p<0.05.
doi: 10.1371/journal.pone.0078178.g005
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Figure 6.  Effect of ghrelin (4 µM) on the mPSCs in the GnRH neurons of the female metestrous mice.  a) Ghrelin decreased
the frequency of the mPSCs (N=14) with no change in the shape of the individual mPSCs (insets). Time course of instantaneous
frequency is depicted under the mPSC-recording. b) Effect of ghrelin on the mPSCs was abolished by the pretreatment with AM251
(N=11). c) Intracellularly applied THL eliminated the ghrelin-evoked changes on the mPSCs (N=10). d) Bar graph reveals that
ghrelin significantly diminished the frequency of mPSCs. Arrow shows the onset of ghrelin administration. *=p<0.05.
doi: 10.1371/journal.pone.0078178.g006
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Pericam transgenic mouse model [67] where the intracellular
Ca2+-content can be monitored real-time in individual GnRH
neurons of the acute brain slice, the ratio of the GnRH neurons
bursting with high/low frequency did not change throughout the
estrous cycle [55]. Another study reported decreased electrical
activity in GnRH neurons of Pericam mice in proestrus
(compared to diestrus) and in adult (compared to prepubertal)
by measuring the calcium transients in these neurons [60]. This
is in contrast with other reports demonstrating increased
electrical activity of GnRH neurons in proestrus [64-66,68-70].
Discrepancy could be due to the different temperature during
recording, slice thickness, flow rate of the extracellular solution,
O2/CO2 bubbling, composition of aCSF, the different genetic
design of the transgenic mouse strain and many other details
of the experimental design. In addition, the results with the
Pericam mice emphasizes that the E2 feedback in the GnRH
neurons of the mouse brain is likely to be multimodal in nature
with differing mechanistic and temporal domains for each mode
and the acute actions of E2 may be one contributor to the
feedback mechanism [71].
Our loose-patch recordings revealed a decreased firing and
bursting activity of the GnRH neurons of both the metestrous
and male mice due to the ghrelin administration. The result is
supported by the ex vivo observation showing a reduction in
the GnRH pulse frequency resulted from ghrelin administration
in male rats [19]. The GnRH-release measured in hypothalamic
fragments in OVX rats was also suppressed upon in vitro
ghrelin application [20]. Effect of ghrelin on the reproductive
axis, however, is rather complex because it highly depends on
the site of action. Acting at the level of hypothalamus ghrelin
inhibits the axis, while at the level of anterior pituitary it seems
to stimulate the release of LH under in vitro conditions [72].
Interestingly, ghrelin treatment did not change the firing and
bursting activities of the GnRH neurons in proestrous mice,
indicating a strong estrous-cycle dependency of the cellular
processes activated by ghrelin. E2 pretreatment inhibited the
ghrelin-evoked rise in the intracellular Ca2+-concentration in the
Figure 7.  Schematic illustration of E2-dependent effects of ghrelin in GnRH neuron.  E2: 17β-estradiol; ER: estrogen
receptor; GHS-R: ghrelin receptor; Gβγ and Gαq: G-protein subunits; DAG: diacylglycerol; DGL: DAG-lipase; CB1: cannabinoid
receptor type-1; AM251: CB1 antagonist; 2-AG: 2-arachidonoylglycerol; THL: tetrahydrolipstatin (DAG-lipase inhibitor); PIP2:
phosphatidylinositol 4,5-bisphosphate; PLC: phospholipase-C; GABAA-R: GABAA receptor; [Ca2+]i: intracellular free calcium; VGCC:
voltage-gated calcium channel; JMV2959: GHS-R antagonist. Dashed arrow denotes putative indirect action.
Binding of ghrelin to GHS-R increases intracellular free Ca2+-content E2-dependently, that in turn activates synthesis and release of
2-AG in the postsynaptic GnRH neuron. The released endocannabinoid then binds to the CB1 located in the presynaptic terminal
and eventually causes suppression of GABA release into the synaptic cleft.
doi: 10.1371/journal.pone.0078178.g007
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GT1-7 neurons suggesting that E2 might be responsible for this
phenomenon.
Action of ghrelin involved activation of a retrograde
endocannabinoid signaling mechanism
The results presented here revealed that the
endocannabinoid signaling pathway was activated in GnRH
neurons when ghrelin administration altered firing properties.
Involvement of the endocannabinoid system in the function of
GnRH neurons has recently been shown in our laboratory by
verifying that endocannabinoids could diminish firing rate in the
GnRH neuron measured [41]. Another study has also
demonstrated that release of endocannabinoids could mediate
the function of GnRH neurons [73]. The finding that ghrelin
could trigger endocannabinoid release in GnRH neurons is
supported by the above-mentioned recent work revealing that
prostaglandin could also promote endocannabinoid synthesis
whereas estrogen was suggested to decrease the
endocannabinoid production in GnRH neurons [73].
In order to further investigate the mechanism whereby
ghrelin is capable of decreasing the firing activity of GnRH
neurons, whole cell patch clamp measurements were carried
out. The experiments revealed that ghrelin was able to
decrease the mPSC frequency. Similar effect of ghrelin has
recently been described in pyramidal neurons of the lateral
nucleus of the amygdala where it also diminished the
frequency of mPSCs [33]. However, while the mPSCs in the
amygdala related to glutamate neurotransmission [33], the
mPSCs recorded in the GnRH neurons represented activation
of the GABAA-R [41,42]. Whereas GABA acts as the major
inhibitory neurotransmitter in the adult hypothalamus [74], and
in vivo studies also showed reduced gonadotropin secretion
resulted from GABA icv injection suggesting putative inhibitory
effect of GABA on the GnRH neurons [75], in vitro experiments
demonstrated excitatory responses by activating GABAA-R in
the GnRH neurons of adult mice [29,30,76] and rats [31,77].
This contradiction can be explained by considering the different
ways of application of GABA: in in vitro experiments GABA was
applied to the GnRH neurons only, while in in vivo
examinations GABA was administered icv and therefore it
acted not only on GnRH neurons but on numerous other
GABA-sensitive neurons in the close vicinity of the 3rd ventricle,
too [78]. The excitatory GABA neurotransmission is considered
as one of the main input drives for the GnRH neurons and
numerous studies demonstrated that the frequency of the
GABAergic mPSCs are in a positive correlation with the firing
activity of these neurons [41,79-81]. Not surprisingly, the
ghrelin-evoked decrease in the firing rate of the GnRH neurons
also correlated with the ghrelin-triggered reduction in the
frequency of mPSCs. One can therefore conclude that the
diminished firing rate observed in GnRH neurons after ghrelin
administration might be partially due to the altered frequency of
mPSCs resulted from application of ghrelin.
Our earlier work provided evidence that endocannabinoid
release from GnRH neurons resulted in a decreased
GABAergic neurotransmission to the GnRH neurons via
GABAA-R [41]. Therefore, the ghrelin-triggered reduction in the
frequency of the mPSCs found in the present experiments
suggested a pivotal role of the retrograde endocannabinoid
signaling machinery in the manifestation of the effect of ghrelin.
Indeed, our recordings of the mPSCs of the GnRH neurons
under pretreatment with AM251 or with the intracellularly
applied THL showed involvement of retrograde
endocannabinoid signaling mechanism in the execution of
ghrelin-evoked changes observed in the mPSCs of the GnRH
neuron and subsequently, in their firing. We have previously
demonstrated similar ghrelin-triggered endocannabinoid
machinery in other neurosecretory systems of the
hypothalamus. Parvicellular neurons of the hypothalamic
paraventricular nucleus, for example, were shown to
synthesize and release endocannabinoids as a result of ghrelin
application [32]. In the parvicellular system, the ghrelin-
activated retrograde endocannabinoid signal also resulted in a
decrease in the frequency of the mPSCs supporting the
concept that ghrelin utilizes this machinery to alter the mPSC
and firing parameters of GnRH neurons. The schematic
diagram (Figure 7.) describes the proposed mechanism of
action of ghrelin where binding of ghrelin to GHS-R activates
synthesis and release of 2-AG which then binds to CB1 located
in the presynaptic terminal and eventually causing suppression
of GABA release into the synaptic cleft.
It is an intriguing question, how ghrelin can access GnRH
neurons, in particularly how the hormone can pass the blood-
brain-barrier (BBB) to reach these neurons. Ghrelin can enter
the brain via multiple routes and access the neurons rapidly.
Ghrelin can leave the bloodstream at fenestrated capillaries
[82]. Therefore, it is possible that it can reach the dendrites of
GnRH neurons approaching the OVLT since these neurons
extend complex dendritic trees outside the BBB [83]. In
addition, ghrelin can pass the intact BBB utilising a triglyceride-
dependent active transport system to regulate not only
hypothalamic functions but learning and memory in the
hippocampus [8,84,85].
The effects of ghrelin observed in our experiments resulted
from the administration of acylated form of ghrelin and its
binding to GHS-R expressed in GnRH neurons. This form was
applied because acylation is indispensable for the binding of
ghrelin to GHS-R [86]. We have to note, however, that we
cannot exclude similar influence of various functions of GnRH
neurons by unacylated form of ghrelin, whose concentration in
plasma and circulating half-life exceeds that of acylated ghrelin.
In vivo experiments demonstrated that unacylated form could
mimic the inhibitory effects of the acylated form on the gonadal
axis [87]. Both forms were able to reduce circulating level of LH
and FSH under various circumstances and therefore
modulating functions of gonads [87]. Unacylated form,
however, is suggested to act partially via a GHS-R-
independent pathway [87,88]. Therefore, putative effect of the
unacylated form on the functions of GnRH neurons requires
further elucidation.
In this study, we provided evidence that ghrelin is able to act
directly on GnRH neurons in an estrous-cycle-dependent
manner, and this action is mediated by a retrograde
endocannabinoid signaling mechanism. Nevertheless,
increasing amount of evidence suggests that this machinery
could be involved in certain human (patho)physiological
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condition, too. Literature data showed that ghrelin could
partially be involved in the suppression of spontaneous
secretion of LH in humans [22-24]. In pathological condition,
such as anorexia nervosa where high serum ghrelin level and
infertility are detected, a relation between these two features of
the disorder could also be hypothesized [89-93]. Nevertheless,
whether such a relationship exists indeed in humans, requires
further elaboration.
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